| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/13/1997 | WO1997009325A1 Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions |
| 03/13/1997 | WO1997009320A1 Alternate crystal form of tazofelone |
| 03/13/1997 | WO1997009315A1 Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions |
| 03/13/1997 | WO1997009056A1 Extract of iridaceae and compositions containing such extract |
| 03/13/1997 | WO1997009046A1 Compounds and methods |
| 03/13/1997 | WO1997009032A1 Utilization of an extract of a non photosynthetic filamentary bacterium and composition containing such extract |
| 03/13/1997 | WO1997001360A3 Compounds with chelation affinity and selectivity for first transition series elements and their use in medical therapy and diagnosis |
| 03/13/1997 | CA2231182A1 Recombinant anti-cd4 antibodies for human therapy |
| 03/13/1997 | CA2231132A1 Alternate crystal form of tazofelone |
| 03/13/1997 | CA2230896A1 Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions |
| 03/13/1997 | CA2230894A1 Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions |
| 03/13/1997 | CA2229036A1 Substituted phosphinic compounds and their use as pharmaceuticals |
| 03/12/1997 | EP0761685A2 Macrophage-derived inflammatory mediator (mip-1 alpha and mip-1 beta) |
| 03/12/1997 | EP0761661A1 Glycomimetics as selectin antagonists, and anti-inflammatory agents prepared thereof |
| 03/12/1997 | EP0761656A1 Alternate crystal form of tazofelone ((+,-)-5-((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)methyl)-4-thiazolidinone) |
| 03/12/1997 | EP0761650A1 Thermally stable and storable crystalline modification of N-methyl-N-((1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)-ethyl)-2,2-diphenyl-acetamide and process for its preparation |
| 03/12/1997 | EP0761217A1 Ready-to-use eye lotion containing indomethacin |
| 03/12/1997 | EP0761211A1 Sustained release composition |
| 03/12/1997 | EP0761204A1 Use of extracts of filamentous, non photosynthetic bacteria and the composition containing them |
| 03/12/1997 | EP0760811A1 Imidazole derivatives as histamine receptor h 3? (ant)agonists |
| 03/12/1997 | EP0760668A1 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
| 03/12/1997 | EP0760667A1 Cancer treatment and metastasis prevention |
| 03/12/1997 | EP0760664A1 Use of pteridine derivatives as no-synthase inhibitors |
| 03/12/1997 | EP0760661A1 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
| 03/12/1997 | EP0760602A1 Use of fas ligand to suppress lymphocyte-mediated immune responses |
| 03/12/1997 | EP0693059B1 Perhydroisoindole derivatives, preparation thereof and pharmaceutical compositions containing same |
| 03/12/1997 | EP0665830B1 Tilidin dihydrogen orthophosphate, method of preparing it and pharmaceutical preparations containing it |
| 03/12/1997 | EP0565587B1 THE EFFECT OF N,N,N-TRIMETHYLSPHINGOSINE ON PROTEIN KINASE-C ACTIVITY; MELANOMA CELL GROWTH $i(IN VITRO); METASTATIC POTENTIAL $i(IN VIVO) AND HUMAN PLATELET AGGREGATION |
| 03/12/1997 | CN1145071A Heterocyclic compounds and their preparation and use |
| 03/12/1997 | CN1144655A Indomethacin adhesive plaster |
| 03/11/1997 | US5610279 Human TNF receptor |
| 03/11/1997 | US5610183 Phenylglycine derivatives pharmaceutical compositions containing them and their use in therapy |
| 03/11/1997 | US5610176 Tachykinin (NK1) receptor antagonists |
| 03/11/1997 | US5610145 Carbamate stereoisomers |
| 03/11/1997 | US5610144 Pyrrolidine and thiazolidine derivatives, their preparation and medicaments containing them |
| 03/11/1997 | US5609884 Controlled release naproxen sodium plus naproxen combination tablet |
| 03/07/1997 | CA2184881A1 Glycomimetics as selectin antagonists and pharmaceuticals having antiinflammatory activity prepared therefrom |
| 03/06/1997 | WO1997008207A1 Fluorinated sialyl-lewis x derivatives and intermediates for synthesis thereof |
| 03/06/1997 | WO1997008202A1 Antisecretory factor peptides regulating pathological permeability changes |
| 03/06/1997 | WO1997008166A1 Piperazino derivatives as neurokinin antagonists |
| 03/06/1997 | WO1997008144A1 Substituted benzylaminopiperidine compounds |
| 03/06/1997 | WO1997008143A1 Inhibitors of tumor necrosis factor alpha |
| 03/06/1997 | WO1997008133A1 Amide compounds and use of the same |
| 03/06/1997 | WO1997007828A1 Therapy for cellular accumulation in chronic inflammatory diseases |
| 03/06/1997 | WO1997007791A1 Use of aminoadamantane compounds as immunoregulators |
| 03/06/1997 | WO1997005285A3 Methods and compositions for identifying morphogen analogs |
| 03/06/1997 | CA2502764A1 Amide compounds |
| 03/06/1997 | CA2230852A1 Therapy for cellular accumulation in chronic inflammatory diseases |
| 03/06/1997 | CA2230487A1 Inhibitors of tumor necrosis factor alpha |
| 03/05/1997 | EP0759985A1 Transgenic arthritic mice |
| 03/05/1997 | EP0759983A1 Dna encoding the beta subunit of a mammalian "maxi-k" potassium channel |
| 03/05/1997 | EP0759980A1 Interleukin-6 splice variant |
| 03/05/1997 | EP0759943A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof |
| 03/05/1997 | EP0759922A1 New antagonist compounds |
| 03/05/1997 | EP0759899A1 Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities |
| 03/05/1997 | EP0759783A1 Anti-inflammatory wound healing compositions and methods for preparing and using same |
| 03/05/1997 | EP0759770A1 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
| 03/05/1997 | EP0759766A1 EXTRACTS OF $i(STEPHANIA TETRANDRA) FOR INHIBITION OF INTERLEUKIN-6 PRODUCTION |
| 03/05/1997 | EP0759759A1 P75 tnf receptor promoters |
| 03/05/1997 | EP0759758A1 Sialic acid/fucose based medicaments |
| 03/05/1997 | EP0759757A1 Oral liquid alendronate formulations |
| 03/05/1997 | EP0759752A1 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 03/05/1997 | EP0759751A1 Process for the preparation of acanthoic acid and pharmaceutical composition comprising same |
| 03/05/1997 | EP0623122B1 Benzopyran and related LTB4-antagonists. |
| 03/05/1997 | EP0591333B1 Azanorbornane derivatives |
| 03/05/1997 | CN1144480A Guanylhydrazones for treating inflammatory conditions |
| 03/05/1997 | CN1144091A Compounds having retinoid-like activity |
| 03/05/1997 | CN1034175C Pyrazolopyrimidines compound |
| 03/04/1997 | US5608095 Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents |
| 03/04/1997 | US5608093 Corticosteroid 17-alkyl carbonate 21-[0]-carboxylic and carbonic esters, and pharmaceuticals containing these compounds |
| 03/04/1997 | US5607959 Analgesics |
| 03/04/1997 | US5607943 Cardioprotective, cerebroprotective, antiinflammatory agents |
| 03/04/1997 | US5607933 3-arylcarbonyl-1(C-attached-N-heteryl)-1H-indoles |
| 03/04/1997 | US5607930 1,4-disubstituted piperazines useful in the therapy of the asthma and of the inflammation of the respiratory tract |
| 03/04/1997 | US5607690 Diclofenac, hydroxyethyl-pyrroldine or piperidine |
| 02/27/1997 | WO1997007334A1 Axial flow valve system for linear compressor |
| 02/27/1997 | WO1997007208A1 Nucleic acid molecules encoding peptides having pronociceptive properties |
| 02/27/1997 | WO1997007198A2 Dna sequences and secreted proteins encoded thereby |
| 02/27/1997 | WO1997007115A1 Benzenesulphonamide derivatives as bradykinine antagonists |
| 02/27/1997 | WO1997006791A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF αvβ5 MEDIATED ANGIOGENESIS |
| 02/27/1997 | WO1997006790A1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 02/27/1997 | WO1997003188A3 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 02/27/1997 | WO1997001579A3 Somatostatin peptides |
| 02/27/1997 | DE19531342A1 Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren Use of aminoadamantane compounds as immune regulators |
| 02/27/1997 | CA2229208A1 Dna sequences and secreted proteins encoded thereby |
| 02/27/1997 | CA2229135A1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 02/26/1997 | EP0759432A1 Use of medicaments containing 3,4-diaryl furans and analogs thereof for treating a skin-related condition |
| 02/26/1997 | EP0759087A1 Compositions and methods for targeting gene delivery vehicles |
| 02/26/1997 | EP0759027A1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 02/26/1997 | EP0759026A1 Amide derivatives and their therapeutic use |
| 02/26/1997 | EP0759025A1 Amide derivatives and their therapeutic use |
| 02/26/1997 | EP0758904A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases |
| 02/26/1997 | EP0758900A1 Method for reduction of headache pain |
| 02/26/1997 | EP0758892A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor |
| 02/26/1997 | EP0758891A1 HALOMETHYL AMIDES AS IL-1$g(b) PROTEASE INHIBITORS |
| 02/26/1997 | EP0758889A1 Solid pharmaceutical compositions containing (s)-2-(4-isobutylphenyl)propionic acid active ingredient and microcrystalline cellulose and colloidal silica as excipients |
| 02/26/1997 | EP0758888A1 Matrix system for the transdermal delivery of ibuprofen, and method for preparing same |
| 02/26/1997 | EP0630382B1 Lactam dipeptides having hle inhibiting activity |
| 02/26/1997 | EP0587819B1 Medetomidine preparations for transdermal administration |
| 02/26/1997 | EP0519976B1 Neutrophil stimulating peptides |